We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Zambon acquires Breath Therapeutics to advance inhalation therapy for BOS
Zambon, an Italian multinational company, extends its presence in severe respiratory diseases through the acquisition of Breath Therapeutics (Credit: Pixabay)